# Crescent (CBIO) — Analyst Forecast

CBIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cbio/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 6, 2026 | HC Wainwright & Co. | Upgraded | Neutral → Buy | $36.00 |
| Sep 14, 2026 | Wedbush | Maintained | Outperform | $27.00 |
| Aug 27, 2026 | Wedbush | Maintained | Outperform | $27.00 |
| Jun 1, 2026 | HC Wainwright & Co. | Downgraded | Buy → Neutral | — |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | $22.00 |
| Jan 21, 2026 | Guggenheim | Initiated Coverage | Buy | $35.00 |
| Aug 27, 2025 | HC Wainwright & Co. | Maintained | Buy | $25.00 |
| Aug 25, 2025 | Jefferies | Initiated Coverage | Buy | $26.00 |
| Aug 11, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $25.00 |
| Jul 14, 2025 | Wedbush | Initiated Coverage | Outperform | $27.00 |
| Jun 25, 2025 | Stifel | Initiated Coverage | Buy | $28.00 |
| Jun 18, 2025 | LifeSci Capital | Initiated Coverage | Outperform | $22.00 |
| Mar 21, 2025 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| Jul 26, 2024 | TD Cowen | Downgraded | Buy → Hold | — |
| Jun 4, 2024 | HC Wainwright & Co. | Maintained | Neutral | — |
| May 6, 2024 | HC Wainwright & Co. | Downgraded | Buy → Neutral | — |
| Mar 27, 2024 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Dec 22, 2023 | Capital One | Initiated Coverage | Overweight | $12.00 |
| Aug 3, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jun 15, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |

## Frequently Asked Questions

### Is CBIO a buy, sell, or hold?

Analysts covering Crescent currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on CBIO?

On Oct 6, 2026, HC Wainwright & Co. upgraded Crescent to Buy with a price target of $36.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).